Latent PDGFD, His, Human
Latent PDGFD, His, Human

Latent PDGFD, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Latent PDGFD, His, Human

Platelet‑derived growth factor D (PDGF‑D) is a new member of the PDGF family that binds the PDGFR‑β homodimer. PDGF‑D promotes the angiogenic capacity of EPCs, including proliferation, migration, adhesion and tube formation, and thereby contributes to angiogenesis.
Z05739
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
His Latent PDGFD (Arg19-Arg370)_x000D_
Accession # Q9GZP0-1
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 41.82 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • Latent PDGFD, His, Human
    • Latent PDGFD, His, Human

    Latent PDGFD, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Platelet‑derived growth factor D (PDGF‑D) is a new member of the PDGF family that binds the PDGFR‑β homodimer. PDGF‑D promotes the angiogenic capacity of EPCs, including proliferation, migration, adhesion and tube formation, and thereby contributes to angiogenesis.
Synonyms PDGF-D; SCDGF-B; IEGF; SCDGFB

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.